SCHEMBL10352273

SCHEMBL10352273

Cc1coc(=O)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8313465 0.77
SCHEMBL15030959 0.75 ALDH1A1 (0.50)
SCHEMBL8085087 0.72 KDM4E (0.42)
SCHEMBL791667 0.65
SCHEMBL18021729 0.64 ALOX15 (0.49)
SCHEMBL12189091 0.63 ALDH1A1 (0.44)
SCHEMBL4141025 0.62 TYR (0.64)
SCHEMBL12168966 0.62 ALDH1A1 (0.33)
SCHEMBL9372906 0.62
SCHEMBL12987762 0.61 ALDH2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9265767-B2 1,2-disubstituted heterocyclic compounds FORUM PHARMACEUTICALS INC. (US) 2016-02-23 US disclosed
US-20150274706-A1 1,2-DISUBSTITUTED HETEROCYCLIC COMPOUNDS FMR LLC 2015-10-01 US disclosed
US-20140011808-A1 1,2-DISUBSTITUTED HETEROCYCLIC COMPOUNDS FMR LLC 2014-01-09 US disclosed
US-8071595-B2 1,2-disubstituted heterocyclic compounds ENVIVO PHARMACEUTICALS, INC. (US) 2011-12-06 US disclosed
EP-0195743-B1 ENOL ETHERS, PROCESS FOR THEIR PREPARATION, ALPHA-PYRONES, PROCESS FOR THEIR PREPARATION AND USE OF THE ALPHA-PYRONES CIBA-GEIGY AG (CH) 1990-08-01 EP disclosed